Myasthenia gravis trials in Austria

5 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Enrolling by invitation
  Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

  Where

  Vienna

  Age

  2 years to 18 years

  People

  12 worldwide

  Run by

  argenx

  See details and how to joinNCT05374590 · EU 2023-507379-23-00
• Phase 3Taking people
  Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  Where

  Vienna

  Age

  18 years to 74 years

  People

  115 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT07217587 · EU 2025-521130-28-00
• Phase 3Taking people
  A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

  Where

  Linz, Salzburg, Schwarzach Im Pongau, Wels

  Age

  18 years to 80 years

  People

  195 worldwide

  Run by

  Dianthus Therapeutics

  See details and how to joinNCT07647510 · EU 2026-525298-38-00
• No phaseTaking people
  Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  Where

  Vienna

  Age

  18 years and over

  People

  500 worldwide

  Run by

  Alexion Pharmaceuticals, Inc.

  See details and how to joinNCT04202341
• No phaseTaking people
  A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

  Where

  Linz

  Age

  18 years and over

  People

  680 worldwide

  Run by

  argenx

  See details and how to joinNCT06298565